Meet our Experts this May for the Good Morning Meeting, Organized by MVA
Innovative Strategies for Oncology and CNS Drug Discovery
This meeting will present current approaches and technologies in drug discovery within oncology and neuroscience research. The programme brings together perspectives on how different preclinical strategies and model systems support drug development from early discovery through IND.
Key aspects of antibody–drug conjugate (ADC) development will be covered, including considerations related to efficacy, safety, and resistance. Approaches to improving targeting, stability, and overall therapeutic performance will be outlined, alongside examples from ongoing research programs.
The meeting will also address challenges in central nervous system (CNS) drug discovery, focusing on how different experimental models are used to study disease mechanisms and evaluate drug candidates. Particular attention will be given to the role of in vitro systems, organoid models, and in vivo studies in generating translationally relevant data.
We look forward to connecting with you.
Event: Good Morning Meeting, Organized by Medicon Valley Alliance (MVA)
Date: May 20, 2026
Time: 8:00 – 11:00
Venue: Medicon Valley Alliance, Arne Jacobsens Allé 15, 2300 Copenhagen S, Denmark – Hub 2
